$TECH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-TECHNE Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIO-TECHNE Corp. Get notifications about new insider transactions in BIO-TECHNE Corp for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 8 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 02 2015 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Option Exercise | A | 87.34 | 4,260 | 372,068 | 4,260 | ||
| Nov 02 2015 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Grant | A | 0.00 | 1,059 | 0 | 2,059 | 1,000 to 2.1 K (+105.90 %) | |
| Nov 02 2015 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | A | 87.34 | 4,260 | 372,068 | 4,260 | ||
| Nov 02 2015 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Grant | A | 0.00 | 1,059 | 0 | 3,059 | 2 K to 3.1 K (+52.95 %) | |
| Nov 02 2015 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Option Exercise | A | 87.34 | 4,260 | 372,068 | 4,260 | ||
| Nov 02 2015 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Grant | A | 0.00 | 1,059 | 0 | 6,559 | 5.5 K to 6.6 K (+19.25 %) | |
| Nov 02 2015 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Option Exercise | A | 87.34 | 4,260 | 372,068 | 4,260 | ||
| Nov 02 2015 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Grant | A | 0.00 | 1,059 | 0 | 6,059 | 5 K to 6.1 K (+21.18 %) | |
| Aug 20 2015 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
| Aug 20 2015 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 108.49 | 9,375 | 1,017,094 | 9,375 | |
| Aug 19 2015 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Option Exercise | M | 66.90 | 5,000 | 334,500 | 0 | |
| Aug 19 2015 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Sell | S | 106.02 | 5,000 | 530,112 | 3,456 | 8.5 K to 3.5 K (-59.13 %) |
| Aug 19 2015 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Buy | M | 66.90 | 5,000 | 334,500 | 8,456 | 3.5 K to 8.5 K (+144.68 %) |
| Aug 17 2015 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Option Exercise | M | 61.46 | 5,000 | 307,300 | 0 | |
| Aug 17 2015 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Sell | S | 106.01 | 5,000 | 530,035 | 3,456 | 8.5 K to 3.5 K (-59.13 %) |
| Aug 17 2015 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Buy | M | 61.46 | 5,000 | 307,300 | 8,456 | 3.5 K to 8.5 K (+144.68 %) |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | VERONNEAU MARCEL | SVP - Clinical Cont ... | Option Exercise | A | 0.00 | 600 | 0 | 600 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | VERONNEAU MARCEL | SVP - Clinical Cont ... | Option Exercise | A | 108.49 | 3,750 | 406,838 | 3,750 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | VERONNEAU MARCEL | SVP - Clinical Cont ... | Option Exercise | A | 108.49 | 7,500 | 813,675 | 7,500 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | A | 108.49 | 6,250 | 678,063 | 6,250 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Senior V.P. Protein ... | Option Exercise | A | 108.49 | 12,500 | 1,356,125 | 12,500 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 0.00 | 800 | 0 | 800 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 108.49 | 5,000 | 542,450 | 5,000 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 108.49 | 10,000 | 1,084,900 | 10,000 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 108.49 | 12,500 | 1,356,125 | 12,500 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 108.49 | 25,000 | 2,712,250 | 25,000 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 108.49 | 6,250 | 678,063 | 6,250 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 108.49 | 12,500 | 1,356,125 | 12,500 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 0.00 | 800 | 0 | 800 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 108.49 | 5,000 | 542,450 | 5,000 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 108.49 | 10,000 | 1,084,900 | 10,000 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Payment of Exercise | F | 97.54 | 277 | 27,019 | 2,223 | 2.5 K to 2.2 K (-11.08 %) |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 0.00 | 11,522 | 0 | 11,522 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 108.49 | 79,517 | 8,626,799 | 79,517 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 108.49 | 79,517 | 8,626,799 | 79,517 | |
| Aug 11 2015 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Grant | A | 0.00 | 11,522 | 0 | 44,377 | 32.9 K to 44.4 K (+35.07 %) |
| Jul 06 2015 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP Biotech | Option Exercise | M | 0.00 | 1,667 | 0 | 3,333 | |
| Jul 06 2015 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP Biotech | Payment of Exercise | F | 96.54 | 531 | 51,263 | 1,136 | 1.7 K to 1.1 K (-31.85 %) |
| Jul 06 2015 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP Biotech | Buy | M | 0.00 | 1,667 | 0 | 1,667 | 0 to 1.7 K |
| Jun 09 2015 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Sell | S | 99.39 | 1,000 | 99,386 | 1,000 | 2 K to 1,000 (-50.00 %) |
| Jun 09 2015 | TECH | BIO-TECHNE Corp | VERONNEAU MARCEL | SVP - Clinical Cont ... | Option Exercise | M | 79.41 | 385 | 30,573 | 0 | |
| Jun 09 2015 | TECH | BIO-TECHNE Corp | VERONNEAU MARCEL | SVP - Clinical Cont ... | Buy | M | 79.41 | 385 | 30,573 | 34,989 | 34.6 K to 35 K (+1.11 %) |
| Jun 09 2015 | TECH | BIO-TECHNE Corp | VERONNEAU MARCEL | SVP - Clinical Cont ... | Payment of Exercise | F | 98.75 | 309 | 30,514 | 34,604 | 34.9 K to 34.6 K (-0.89 %) |
| Apr 02 2015 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,666 | 0 | 3,334 | |
| Apr 02 2015 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Payment of Exercise | F | 100.29 | 566 | 56,764 | 1,100 | 1.7 K to 1.1 K (-33.97 %) |
| Apr 02 2015 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 0.00 | 1,666 | 0 | 1,666 | 0 to 1.7 K |
| Feb 20 2015 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Option Exercise | M | 56.17 | 5,000 | 280,850 | 0 | |
| Feb 20 2015 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Sell | S | 95.78 | 5,000 | 478,882 | 70,000 | 75 K to 70 K (-6.67 %) |
| Feb 20 2015 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Buy | M | 56.17 | 5,000 | 280,850 | 75,000 | 70 K to 75 K (+7.14 %) |
| Feb 06 2015 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Option Exercise | M | 54.91 | 1,500 | 82,365 | 0 | |
| Feb 06 2015 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Buy | M | 54.91 | 1,500 | 82,365 | 5,500 | 4 K to 5.5 K (+37.50 %) |
| Dec 12 2014 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Sell | S | 92.40 | 1,000 | 92,400 | 1,000 | 2 K to 1,000 (-50.00 %) |
| Dec 10 2014 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Sell | S | 90.44 | 3,000 | 271,320 | 4,000 | 7 K to 4 K (-42.86 %) |
| Dec 09 2014 | TECH | BIO-TECHNE Corp | REAGAN KEVIN J | Senior VP - Biotech | Option Exercise | M | 70.96 | 2,591 | 183,857 | 7,182 | |
| Dec 09 2014 | TECH | BIO-TECHNE Corp | REAGAN KEVIN J | Senior VP - Biotech | Option Exercise | M | 70.96 | 1,000 | 70,960 | 9,773 | |
| Dec 09 2014 | TECH | BIO-TECHNE Corp | REAGAN KEVIN J | Senior VP - Biotech | Sell | S | 89.32 | 2,591 | 231,432 | 0 | 2.6 K to 0 (-100.00 %) |
| Dec 09 2014 | TECH | BIO-TECHNE Corp | REAGAN KEVIN J | Senior VP - Biotech | Buy | M | 70.96 | 2,591 | 183,857 | 2,591 | 0 to 2.6 K |
| Dec 09 2014 | TECH | BIO-TECHNE Corp | REAGAN KEVIN J | Senior VP - Biotech | Sell | S | 89.41 | 1,000 | 89,412 | 0 | 1,000 to 0 (-100.00 %) |
| Dec 09 2014 | TECH | BIO-TECHNE Corp | REAGAN KEVIN J | Senior VP - Biotech | Buy | M | 70.96 | 1,000 | 70,960 | 1,000 | 0 to 1,000 |
| Dec 03 2014 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Sen. VP Protein Pla ... | Option Exercise | A | 90.25 | 5,000 | 451,250 | 5,000 | |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Option Exercise | A | 91.78 | 4,000 | 367,120 | 4,000 | |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Option Exercise | A | 91.78 | 4,000 | 367,120 | 4,000 | |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Grant | A | 0.00 | 1,000 | 0 | 1,500 | 500 to 1.5 K (+200.00 %) |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Option Exercise | A | 91.78 | 4,000 | 367,120 | 4,000 | |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Option Exercise | A | 91.78 | 4,000 | 367,120 | 4,000 | |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Option Exercise | A | 91.78 | 4,000 | 367,120 | 4,000 | |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Grant | A | 0.00 | 1,000 | 0 | 7,000 | 6 K to 7 K (+16.67 %) |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Option Exercise | A | 91.78 | 4,000 | 367,120 | 4,000 | |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Option Exercise | A | 91.78 | 4,000 | 367,120 | 4,000 | |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Option Exercise | A | 91.78 | 4,000 | 367,120 | 4,000 | |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Grant | A | 0.00 | 1,000 | 0 | 3,456 | 2.5 K to 3.5 K (+40.72 %) |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | A | 91.78 | 4,000 | 367,120 | 4,000 | |
| Nov 03 2014 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Grant | A | 0.00 | 1,000 | 0 | 5,000 | 4 K to 5 K (+25.00 %) |
| Sep 10 2014 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Option Exercise | M | 54.91 | 5,000 | 274,550 | 1,500 | |
| Sep 10 2014 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Buy | M | 54.91 | 5,000 | 274,550 | 6,000 | 1,000 to 6 K (+500.00 %) |
| Aug 15 2014 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Option Exercise | M | 57.06 | 5,000 | 285,300 | 0 | |
| Aug 15 2014 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Sell | S | 95.54 | 5,000 | 477,700 | 1,000 | 6 K to 1,000 (-83.33 %) |
| Aug 15 2014 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Buy | M | 57.06 | 5,000 | 285,300 | 6,000 | 1,000 to 6 K (+500.00 %) |
| Aug 14 2014 | TECH | BIO-TECHNE Corp | VERONNEAU MARCEL | SVP - Clinical Cont ... | Option Exercise | A | 94.35 | 15,000 | 1,415,250 | 15,000 | |
| Aug 14 2014 | TECH | BIO-TECHNE Corp | REAGAN KEVIN J | Senior VP - Biotech | Option Exercise | A | 94.35 | 15,000 | 1,415,250 | 15,000 | |
| Aug 14 2014 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 94.35 | 35,000 | 3,302,250 | 35,000 | |
| Aug 14 2014 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 94.35 | 80,460 | 7,591,401 | 80,460 | |
| Aug 14 2014 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Grant | A | 0.00 | 11,129 | 0 | 43,984 | 32.9 K to 44 K (+33.87 %) |
| Aug 14 2014 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 94.35 | 15,000 | 1,415,250 | 15,000 | |
| Aug 14 2014 | TECH | BIO-TECHNE Corp | EANSOR N DAVID | SVP - Novus Biologi ... | Option Exercise | A | 94.35 | 15,000 | 1,415,250 | 15,000 | |
| Aug 14 2014 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 94.35 | 15,000 | 1,415,250 | 15,000 | |
| Aug 06 2014 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Jul 07 2014 | TECH | BIO-TECHNE Corp | EANSOR N DAVID | SVP - Novus Biologi ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Jun 03 2014 | TECH | BIO-TECHNE Corp | VERONNEAU MARCEL | VP Clinical Control ... | Option Exercise | M | 56.83 | 510 | 28,983 | 0 | |
| Jun 03 2014 | TECH | BIO-TECHNE Corp | VERONNEAU MARCEL | VP Clinical Control ... | Buy | M | 56.83 | 510 | 28,983 | 34,913 | 34.4 K to 34.9 K (+1.48 %) |
| Jun 03 2014 | TECH | BIO-TECHNE Corp | VERONNEAU MARCEL | VP Clinical Control ... | Payment of Exercise | F | 87.34 | 331 | 28,910 | 34,403 | 34.7 K to 34.4 K (-0.95 %) |
| May 08 2014 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Option Exercise | M | 54.68 | 4,066 | 222,329 | 0 | |
| May 08 2014 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Option Exercise | M | 54.68 | 934 | 51,071 | 4,066 | |
| May 08 2014 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Sell | S | 91.00 | 4,066 | 370,006 | 70,000 | 74.1 K to 70 K (-5.49 %) |
| May 08 2014 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Buy | M | 54.68 | 4,066 | 222,329 | 74,066 | 70 K to 74.1 K (+5.81 %) |
| May 08 2014 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Sell | S | 91.00 | 934 | 84,994 | 70,000 | 70.9 K to 70 K (-1.32 %) |
| May 08 2014 | TECH | BIO-TECHNE Corp | OCONNELL HOWARD V | Director | Buy | M | 54.68 | 934 | 51,071 | 70,934 | 70 K to 70.9 K (+1.33 %) |
| May 15 2014 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Option Exercise | A | 87.83 | 2,000 | 175,660 | 2,000 | |
| May 15 2014 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Grant | A | 0.00 | 500 | 0 | 500 | 0 to 500 |
| Apr 03 2014 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 86.25 | 46,316 | 3,994,755 | 46,316 | |
| Apr 03 2014 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Grant | A | 0.00 | 10,203 | 0 | 32,855 | 22.7 K to 32.9 K (+45.04 %) |
| Apr 03 2014 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Grant | A | 0.00 | 7,652 | 0 | 22,652 | 15 K to 22.7 K (+51.01 %) |
| Apr 01 2014 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Apr 01 2014 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 86.25 | 10,000 | 862,500 | 10,000 | |
| Apr 01 2014 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 86.25 | 25,000 | 2,156,250 | 25,000 | |
| Mar 06 2014 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Option Exercise | M | 57.06 | 5,000 | 285,300 | 5,000 | |
| Mar 06 2014 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Sell | S | 89.83 | 5,000 | 449,150 | 1,000 | 6 K to 1,000 (-83.33 %) |
| Mar 06 2014 | TECH | BIO-TECHNE Corp | HOLBROOK KAREN A | Director | Buy | M | 57.06 | 5,000 | 285,300 | 6,000 | 1,000 to 6 K (+500.00 %) |
| Feb 28 2014 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Option Exercise | M | 61.46 | 5,000 | 307,300 | 0 | |
| Feb 28 2014 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Sell | S | 88.78 | 5,000 | 443,900 | 1,000 | 6 K to 1,000 (-83.33 %) |
| Feb 28 2014 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Buy | M | 61.46 | 5,000 | 307,300 | 6,000 | 1,000 to 6 K (+500.00 %) |
| Feb 21 2014 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Option Exercise | M | 66.59 | 5,000 | 332,950 | 0 | |
| Feb 21 2014 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Option Exercise | M | 65.47 | 5,000 | 327,350 | 0 | |
| Feb 21 2014 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Option Exercise | M | 63.03 | 5,000 | 315,150 | 0 | |
| Feb 21 2014 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Sell | S | 90.03 | 15,000 | 1,350,507 | 2,456 | 17.5 K to 2.5 K (-85.93 %) |
| Feb 21 2014 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Buy | M | 63.03 | 5,000 | 315,150 | 17,456 | 12.5 K to 17.5 K (+40.14 %) |
| Feb 21 2014 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Buy | M | 65.47 | 5,000 | 327,350 | 12,456 | 7.5 K to 12.5 K (+67.06 %) |
| Feb 21 2014 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Buy | M | 66.59 | 5,000 | 332,950 | 7,456 | 2.5 K to 7.5 K (+203.58 %) |
| Nov 15 2013 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Option Exercise | M | 63.03 | 5,000 | 315,150 | 0 | |
| Nov 15 2013 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Option Exercise | M | 65.47 | 5,000 | 327,350 | 0 | |
| Nov 15 2013 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Option Exercise | M | 66.59 | 5,000 | 332,950 | 0 | |
| Nov 15 2013 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Sell | S | 86.20 | 15,000 | 1,293,000 | 1,000 | 16 K to 1,000 (-93.75 %) |
| Nov 15 2013 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Buy | M | 63.03 | 5,000 | 315,150 | 16,000 | 11 K to 16 K (+45.45 %) |
| Nov 15 2013 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Buy | M | 65.47 | 5,000 | 327,350 | 11,000 | 6 K to 11 K (+83.33 %) |
| Nov 15 2013 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Buy | M | 66.59 | 5,000 | 332,950 | 6,000 | 1,000 to 6 K (+500.00 %) |
| Nov 12 2013 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | M | 56.17 | 5,000 | 280,850 | 0 | |
| Nov 12 2013 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | M | 54.68 | 5,000 | 273,400 | 0 | |
| Nov 12 2013 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Sell | S | 87.00 | 10,000 | 870,000 | 4,000 | 14 K to 4 K (-71.43 %) |
| Nov 12 2013 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Buy | M | 56.17 | 5,000 | 280,850 | 14,000 | 9 K to 14 K (+55.56 %) |
| Nov 12 2013 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Buy | M | 54.68 | 5,000 | 273,400 | 9,000 | 4 K to 9 K (+125.00 %) |
| Nov 05 2013 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Option Exercise | M | 54.68 | 5,000 | 273,400 | 0 | |
| Nov 05 2013 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Option Exercise | M | 56.17 | 5,000 | 280,850 | 0 | |
| Nov 05 2013 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Sell | S | 87.64 | 10,000 | 876,400 | 2,456 | 12.5 K to 2.5 K (-80.28 %) |
| Nov 05 2013 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Buy | M | 54.68 | 5,000 | 273,400 | 12,456 | 7.5 K to 12.5 K (+67.06 %) |
| Nov 05 2013 | TECH | BIO-TECHNE Corp | LUCAS ROGER C | Director | Buy | M | 56.17 | 5,000 | 280,850 | 7,456 | 2.5 K to 7.5 K (+203.58 %) |
| Nov 04 2013 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Option Exercise | A | 87.39 | 4,000 | 349,560 | 4,000 | |
| Nov 04 2013 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Director | Grant | A | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
| Nov 04 2013 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | A | 87.39 | 4,000 | 349,560 | 4,000 | |
| Nov 04 2013 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Grant | A | 0.00 | 1,000 | 0 | 4,000 | 3 K to 4 K (+33.33 %) |
| Nov 04 2013 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Option Exercise | A | 87.39 | 4,000 | 349,560 | 4,000 | |
| Nov 04 2013 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Director | Grant | A | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
| Nov 04 2013 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Option Exercise | A | 87.39 | 4,000 | 349,560 | 4,000 |